Article thumbnail

DESLORATADINE IN TREATMENT OF ALLERGIC RHINITIS: RESULTS OF RANDOMIZED, PLACEBO_CONTROLLED TRIAL

By R.T. Saygitov

Abstract

<em>This review presents the results of randomized placebo controlled trial, aimed at studying the efficiency of modern non sedative antihistamine desloratadine in allergic rhinitis (AR). It is proven demonstratively that the application of desloratadine in comparison with placebo is accompanied by reduction in total symptoms scores, total nasal symptoms score and improvement in nasal airflow patency. In addition, the advantage of desloratadine versus placebo was established for reducing of nasal eosinophil levels. The acquired data confirm that the efficiency of desloratadine for AR corresponds to IA level of evidence.</em><br /><strong><em>Key words: desloratadine, allergic rhinitis, randomizeplacebo_controlled trial.</em></strong

Topics: Pediatrics, RJ1-570
Publisher: "Paediatrician" Publishers LLC
Year: 2008
OAI identifier: oai:doaj.org/article:72c2676f03ac4d599605312aaf64b2d6
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/1682-5535 (external link)
  • https://doaj.org/toc/1682-5527 (external link)
  • http://vsp.spr-journal.ru:80/j... (external link)
  • https://doaj.org/article/72c26... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.